ARCHIVES

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

This article is from The Cancer Letter archive.

Vol. 37 No. 40 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

Susan Sieber, Former NCI Communications Chief, Dead.

January 25, 2002

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

Andrew von Eschenbach Sworn In As NCI Director.

January 25, 2002

Targeted Biopsy More Effective At Selecting Men For Active Surveillance, Study Says

May 30, 2014

House Appropriator Claims NCI, NLM Grants Funded Political Activity, Seeks OIG Probe

March 22, 2013